4th dose of Pfizer vaccine helps prevent infection among health workers

Embargoed until: Publicly released: 2022-08-03 01:00

International

Having a fourth dose of Pfizer's COVID vaccine helped prevent infection according to a study of nearly 30,000 health workers in Israel. The study found that the rate of breakthrough infection was 7% in those who received 4 doses compared to 20% in the group who had only had 3 doses. The authors say this suggests that a fourth vaccine dose was effective in preventing breakthrough COVID-19 infections in health care workers, helping to maintain the function of the health care system during the pandemic.

Media release

From: JAMA

Association of Fourth Pfizer-BioNTech Vaccine Dose With SARS-CoV-2 Infection

JAMA Network Open
Original Investigation

Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

About The Study: Researchers found that 4-dose recipients of the Pfizer-BioNTech vaccine had a lower risk of acquiring COVID-19 than 3-dose recipients during the peak Omicron variant wave in this study of 29,000 health care workers in Israel.

Authors: Allon E. Moses, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.24657)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Hadassah-Hebrew University Medical Center, Israel

Funder: Conflict of Interest Disclosures: None reported.

Media Contact/s

Contact details are only visible to registered journalists.